Premium
FDA approves generic Strattera
Publication year - 2017
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30229
Subject(s) - computer science , business
On May 30, the U.S. Food and Drug Administration approved the first generic versions of Strattera (atomoxetine) to treat attention‐deficit hyperactivity disorder (ADHD) in pediatric and adult patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom